Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Mol Neurobiol. 2018 Mar 24;55(11):8592–8601. doi: 10.1007/s12035-018-0977-0

Table 1.

Subject demographic, cognitive, and pathological data

Characteristic CN (n =11) MCI (n = 13) AD (n =16)
Age (years), mean (SD) 88.6 (6.4) 89.4 (5.6) 82.9 (8.1)
Education (years), mean (SD) 15.3 (3.4) 14.4 (2.4) 15.2 (2.8)
Sex, no. (%)
   Male 9 (81.8) 8 (61.5) 7 (43.8)
   Female 2 (18.2) 5 (38.5) 9 (56.3)
APOE4, no. (%)
   Carrier 5 (45.5) 3 (23.1) 8 (50)
   Non-carrier 6 (54.5) 10 (76.9) 8 (50)
Cognitive performance (Z scorea), mean (SD)
   Mattis dementia rating scale 0.33 (0.60) − 0.50 (0.50) * − 2.02 (0.82)***
   AVLT total learning 0.03 (1.30) − 0.62 (0.92) * − 2.00 (1.04) ***
   Boston naming total, 60 items 1.39 (0.58) 0.13 (0.96) * − 1.59 (1.23) ***
   Stroop color-word interference test 0.10 (0.83) − 0.30 (1.33) − 1.24 (1.14)*
Postmortem pathological score, mean (SD)
   Plaques in the temporal cortex 1.73 (1.40) 1.10 (1.24) 2.72 (0.58)
   Plaques in the frontal cortex 1.41 (1.36) 1.19 (1.23) 2.72 (0.68) **
   Plaques in the whole brain 6.68 (5.85) 4.88 (5.68) 12.84 (3.00) **
   Tangles in the temporal cortex 0.50 (0.50) 0.73 (0.44) 2.56 (0.70) ***
   Tangles in the frontal cortex 0.09 (0.20) 0.17 (0.24) 2.00 (1.21) ***
   Tangles in the whole brain 5.64 (1.49) 5.83 (2.00) 12.31 (3.24) ***
   Braak stage
    I-II no. (%) 0(0) 1 (7.7) 0(0)
    III-IV no. (%) 11(100) 12 (92.3) 6 (37.5)
    V-VI no. (%) 0 (0) 0(0) 10 (62.5)

CN cognitive normal controls, MCI mild cognitive impairment, AD Alzheimer’s disease, AVLT auditory verbal learning test

a

Cognitive testing was done within 1 year of death. All scores were converted to Z scores based on age- and education-corrected norms

*

p < 0.05,

**

p <0.01, and

***

p < 0.001 compared with the CN group using post hoc tests (Tukey HSD) of one-way analysis